General MedicationsINHALATIONStandard

TOBRAMYCIN

Standard Dose

300MG/4ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview TOBRAMYCIN is listed in Drugs@FDA under application 216725 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TOBRAMYCIN Form and strength SOLUTION;INHALATION - 300MG/4ML Sponsor MANKIND PHARMA Submission history Latest submission status date: 2023-06-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOBRAMYCIN is listed in Drugs@FDA under application 216725 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TOBRAMYCIN Form and strength SOLUTION;INHALATION - 300MG/4ML Sponsor MANKIND PHARMA Submission history Latest submission status date: 2023-06-30 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.